WallSt Focus
Total 1039 Posts
Avadel’s $2.1 Billion Deal With Alkermes Could Shake Up Sleep Medicine—Here’s How!
Avadel Pharmaceuticals’ $2.1B acquisition by Alkermes underscores Lumryz’s strong growth and profitability, with added upside tied to FDA approval for a new sleep disorder indication.
Nvidia Soars Past $5 Trillion Valuation: What It Means for Big Tech and AI
Nvidia (NVDA) has just become the first company in history to cross the $5 trillion market capitalization mark, a feat that highlights its leading position in the AI infrastructure race and the overwhelming investor enthusiasm in technology stocks.
Stock Market Today: Stocks Edge Higher as Nvidia Corporation Optimism Rises and Fed Cut on Deck
U.S. stocks rose slightly on Wednesday, with the Nasdaq leading the charge alongside signs of fresh movement in AI and strong expectations for a rate cut by the Federal Reserve.
Avanos Medical Could Be WRS Group’s Next Big Buy: Is A Small-Cap Orthopedic Play On The Move?
Avanos Medical’s sale of its Game Ready unit to WRS Group sharpens focus on core pain and nutrition lines, streamlining operations and sparking fresh acquisition interest.
Datavault AI Surges On Push Into High Value Tech Infrastructure—Is A Breakout Coming?
Datavault AI’s expansion with new hubs in Philadelphia, Georgia, and London signals bold growth as it scales data monetization tech following 467% YoY gains and a key IBM partnership.
Gigacloud’s $18 Million Bet: Can The New Classic Deal Supercharge Its Global Marketplace?
Gigacloud Technology’s acquisition of New Classic Home Furnishing boosts its sourcing network and U.S. reach, signaling strategic growth and supply-chain diversification amid global trade volatility.
Viomi Technology’s Massive Turnaround: Is This Small-Cap the Next Big Thing?
Viomi Technology’s $20M share buyback through 2027 signals confidence post major restructuring and renewed focus on home water systems, sparking investor optimism despite lingering small-cap risks.